Vertex Pharmaceuticals (VRTX) News Today $397.27 +0.63 (+0.16%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 3 Fantastic Stocks That Could Enjoy a Santa Claus RallyDecember 21 at 6:48 AM | fool.comMy Top 10 Stocks to Buy for 2025December 21 at 4:05 AM | fool.comOppenheimer Downgrades Vertex Pharmaceuticals (NASDAQ:VRTX) to Market PerformDecember 21 at 3:17 AM | americanbankingnews.comVertex Pharmaceuticals Faces Uncertainty with Mixed Phase 2 Trial ResultsDecember 21 at 1:27 AM | markets.businessinsider.comVertex announces FDA exands approval for TrikaftaDecember 20 at 4:18 PM | tipranks.comVertex announces FDA approval of AlyftrekDecember 20 at 4:18 PM | tipranks.comVertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis DrugDecember 20 at 4:18 PM | tipranks.comVertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic FibrosisDecember 20 at 3:46 PM | businesswire.comVertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive VariantsDecember 20 at 3:35 PM | businesswire.comBarclays Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $418.00Barclays reduced their price target on shares of Vertex Pharmaceuticals from $509.00 to $418.00 and set an "equal weight" rating for the company in a research report on Friday.December 20 at 1:21 PM | marketbeat.comBMO Capital Markets Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $520.00BMO Capital Markets lowered their target price on shares of Vertex Pharmaceuticals from $566.00 to $520.00 and set an "outperform" rating on the stock in a research note on Friday.December 20 at 12:11 PM | marketbeat.comHC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock PriceHC Wainwright decreased their price objective on shares of Vertex Pharmaceuticals from $600.00 to $535.00 and set a "buy" rating for the company in a report on Friday.December 20 at 9:08 AM | marketbeat.comVertex Pharmaceuticals' (VRTX) Hold Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Vertex Pharmaceuticals in a research note on Friday.December 20 at 9:08 AM | marketbeat.comVertex Pharmaceuticals price target lowered to $520 from $566 at BMO CapitalDecember 20 at 9:03 AM | tipranks.comVertex Pharmaceuticals price target lowered to $441 from $506 at BernsteinDecember 20 at 7:31 AM | tipranks.comVertex Pharmaceuticals price target lowered to $418 from $509 at BarclaysDecember 20 at 5:58 AM | tipranks.comPrincipal Financial Group Inc. Buys 21,649 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Principal Financial Group Inc. increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 410,359 shares of the pharmaceuticalDecember 20 at 5:17 AM | marketbeat.comJim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘I Think You Should Buy The Dip Here’December 19 at 4:46 PM | insidermonkey.comVertex Pharmaceuticals (NASDAQ:VRTX) Lowered to "Market Perform" Rating by OppenheimerOppenheimer downgraded shares of Vertex Pharmaceuticals from an "outperform" rating to a "market perform" rating in a research report on Thursday.December 19 at 2:45 PM | marketbeat.comVertex Pharmaceuticals downgraded to Perform from Outperform at OppenheimerDecember 19 at 2:06 PM | tipranks.comBank of America Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock PriceBank of America lowered their price target on Vertex Pharmaceuticals from $545.00 to $522.00 and set a "buy" rating on the stock in a research report on Thursday.December 19 at 1:16 PM | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Hits New 52-Week Low - What's Next?Vertex Pharmaceuticals (NASDAQ:VRTX) Sets New 52-Week Low - Should You Sell?December 19 at 11:02 AM | marketbeat.comVertex Pharmaceuticals Inc. (VRTX) Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the FirmDecember 19 at 11:02 AM | globenewswire.comVertex Pharmaceuticals Stock Dives After Mixed Drug Study ResultsDecember 19 at 10:31 AM | investopedia.comVertex’s non-opioid painkiller meets trial goal — but investors aren’t soldDecember 19 at 9:23 AM | bizjournals.comVertex Stock Falls After Release Of Phase 2 Results For Suzetrigine StudyDecember 19 at 9:23 AM | markets.businessinsider.comVertex’s non-opioid drug succeeds in back pain trialDecember 19 at 9:23 AM | msn.comHere’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3December 19 at 9:23 AM | finance.yahoo.comVertex Pharmaceuticals Inc (VRTX) Announces Positive Phase 2 Results for Suzetrigine in Painful ...December 19 at 7:08 AM | gurufocus.comVertex Pharma’s suzetrigine meets Phase 2 primary endpoint in radiculopathyDecember 19 at 6:16 AM | tipranks.com2 Unstoppable Stocks to Buy and Hold for the Next DecadeDecember 19 at 4:20 AM | fool.comVertex Pharmaceuticals price target raised to $494 from $490 at StifelDecember 17, 2024 | markets.businessinsider.comVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $494.00 at Stifel NicolausStifel Nicolaus upped their price target on Vertex Pharmaceuticals from $490.00 to $494.00 and gave the stock a "hold" rating in a research note on Monday.December 16, 2024 | marketbeat.comPrediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030December 16, 2024 | fool.com3 Unstoppable Stocks to Buy Right NowDecember 15, 2024 | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by B. Riley Wealth Advisors Inc.B. Riley Wealth Advisors Inc. lowered its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,996 shares of the pharmaceutical compDecember 15, 2024 | marketbeat.comFranklin Resources Inc. Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Franklin Resources Inc. cut its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 476,833 sharesDecember 15, 2024 | marketbeat.comAmerican Trust Invests $680,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)American Trust purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,463 shares of the pharmaceutical company's stock, vDecember 14, 2024 | marketbeat.comWilmington Savings Fund Society FSB Purchases Shares of 4,702 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Wilmington Savings Fund Society FSB acquired a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,702 shares of the pharmaceuDecember 14, 2024 | marketbeat.comRetirement Systems of Alabama Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Retirement Systems of Alabama lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 222,705 shares of the pharmaceutical company'sDecember 13, 2024 | marketbeat.comOddo BHF Asset Management Sas Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Oddo BHF Asset Management Sas bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 17,013 shares of the pharmaceutical company's stock, valued at apDecember 13, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Decatur Capital Management Inc.Decatur Capital Management Inc. cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 47.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 4,695 shares of the pharmaceutical company's stock after selling 4,206 shares duringDecember 13, 2024 | marketbeat.comTri Ri Asset Management Corp Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Tri Ri Asset Management Corp purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 18,762 shDecember 13, 2024 | marketbeat.comSanctuary Advisors LLC Raises Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sanctuary Advisors LLC grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 46.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,903 shares of the pharmaceutical compaDecember 13, 2024 | marketbeat.comAnchor Investment Management LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Anchor Investment Management LLC raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1,352.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,583 shares of theDecember 13, 2024 | marketbeat.comVirtu Financial LLC Has $2.18 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Virtu Financial LLC reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 67.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,682 shares of the pharmaceutical company's stock after selliDecember 13, 2024 | marketbeat.comTD Cowen Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)December 12, 2024 | markets.businessinsider.comWorld Investment Advisors LLC Invests $24.28 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)World Investment Advisors LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 52,206 shares of the pharmaceutical cDecember 12, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Toronto Dominion BankToronto Dominion Bank grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134,202 shares of the pharmaceutical company's stock after acqDecember 12, 2024 | marketbeat.comThe Ultimate Biotech Stock to Buy With $500 Right NowDecember 12, 2024 | fool.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼0.330.61▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4519▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News BioMarin Pharmaceutical News Exact Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTX Stock Alerts